Delivery Order SPE2DB22D3016-SPE2DB26FABC6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,821.90 to AmerisourceBergen Drug Corp for LENVIMA 20 mg daily dose tablets (60-count supply). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20.4K delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose tablets (30-count packages) under a firm fixed price contract. The award, issued on August 4, 2025, with completion targeted for August 25, 2025, represents a non-competitive delivery order executed through the company's existing indefinite delivery contract (IDC) framework. Performance will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $30,669.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 mg daily dose tablets (60-count supply), with an ultimate completion date of August 29, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to furnish...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,223.24 on August 18, 2025, for the supply of LENVIMA 10 mg daily dose tablets (30-count) under a firm fixed-price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of November 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABC6Delivery Order
The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count supply) on November 3, 2025, with completion targeted for November 25, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The SPE2DX contract vehicle functions as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for LENVIMA, an oncology medication, exemplifies the types of specialized pharmaceutical products the company furnishes through the DLA's Medical Supply Chain to support Defense Health Agency operations and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 11/3/25 |